Search Results

Display Settings
Results per page: 25
Sort By: Relevance
Filter
  • 1-25 of  105 results for ""Humans""

Your Filters

Publisher : american medical association Subject : diabetes mellitus, type 2 Subject : glucose intolerance Geographic : united states Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.

  • Authors : Edmonston D; Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2418808. Date of Electronic Publication: 2024 Jun 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Prediabetes Prevalence by Adverse Social Determinants of Health in Adolescents.

  • Authors : Harrison C; Center for Pediatric Research in Obesity and Metabolism, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.; Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Subjects: Prediabetic State*/Prediabetic State*/Prediabetic State*/epidemiology ; Prediabetic State*/Prediabetic State*/Prediabetic State*/ethnology ; Social Determinants of Health*/Social Determinants of Health*/Social Determinants of Health*/statistics & numerical data

  • Source: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2416088. Date of Electronic Publication: 2024 Jun 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Foot and Ankle Care by Podiatrists and Amputations in Patients With Diabetes and Kidney Failure.

  • Authors : Tan TW; Keck School of Medicine of University of Southern California, Los Angeles.; Caldwell B

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetic Foot*/Diabetic Foot*/Diabetic Foot*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2024 Mar 04; Vol. 7 (3), pp. e240801. Date of Electronic Publication: 2024 Mar 04.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Ascertainment of Minimal Clinically Important Differences in the Diabetes Distress Scale-17: A Secondary Analysis of a Randomized Clinical Trial.

  • Authors : Banks J; Department of Management, Policy and Community Health, School of Public Health, University of Texas Health Science Center, Houston.; Institute on Aging, University of Texas Health Science Center, Houston.

Subjects: Diabetes Mellitus, Type 2*; United States ; Adult

  • Source: JAMA network open [JAMA Netw Open] 2023 Nov 01; Vol. 6 (11), pp. e2342950. Date of Electronic Publication: 2023 Nov 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.

  • Authors : Alhiary R; School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/economics ; Drug Approval*/Drug Approval*/Drug Approval*/legislation & jurisprudence

  • Source: JAMA [JAMA] 2023 Aug 15; Vol. 330 (7), pp. 650-657.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

Oral Empagliflozin Receives FDA Approval for Children With Diabetes.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/administration & dosage ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: JAMA [JAMA] 2023 Jul 25; Vol. 330 (4), pp. 307.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease.

  • Authors : Luo J; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Feldman R

Subjects: Diabetes Mellitus, Type 2* ; Sodium-Glucose Transporter 2 Inhibitors* ; Cardiovascular Diseases*

  • Source: JAMA network open [JAMA Netw Open] 2023 Jun 01; Vol. 6 (6), pp. e2317886. Date of Electronic Publication: 2023 Jun 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes.

  • Authors : Essien UR; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles.; Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, California.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: JAMA network open [JAMA Netw Open] 2023 Jun 01; Vol. 6 (6), pp. e2316290. Date of Electronic Publication: 2023 Jun 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Diabetes Care Barriers, Use, and Health Outcomes in Younger Adults With Type 1 and Type 2 Diabetes.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2023 May 01; Vol. 6 (5), pp. e2312147. Date of Electronic Publication: 2023 May 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Association of Health-Related Social Needs With Quality and Utilization Outcomes in a Medicare Advantage Population With Diabetes.

Subjects: Medicare Part C* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/therapy

  • Source: JAMA network open [JAMA Netw Open] 2023 Apr 03; Vol. 6 (4), pp. e239316. Date of Electronic Publication: 2023 Apr 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Exploration of Residual Confounding in Analyses of Associations of Metformin Use and Outcomes in Adults With Type 2 Diabetes.

  • Authors : Powell M; Department of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland.; Clark C

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2022 Nov 01; Vol. 5 (11), pp. e2241505. Date of Electronic Publication: 2022 Nov 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients.

  • Authors : Zhai MZ; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Avorn J

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: JAMA network open [JAMA Netw Open] 2022 Nov 01; Vol. 5 (11), pp. e2240117. Date of Electronic Publication: 2022 Nov 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes.

  • Authors : Zhuo M; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/complications ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/drug therapy ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2022 Oct 03; Vol. 5 (10), pp. e2235995. Date of Electronic Publication: 2022 Oct 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.

  • Authors : Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Tesfaye H

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: JAMA network open [JAMA Netw Open] 2022 Oct 03; Vol. 5 (10), pp. e2237606. Date of Electronic Publication: 2022 Oct 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration.

  • Authors : Woronow D; Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Division of Pharmacovigilance, US Food and Drug Administration, Silver Spring, Maryland.; Chamberlain C

Subjects: Cholecystitis, Acute* ; Diabetes Mellitus, Type 2*; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/agonists

  • Source: JAMA internal medicine [JAMA Intern Med] 2022 Oct 01; Vol. 182 (10), pp. 1104-1106.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534

Record details

Read More Add to Saved list
×
Academic Journal

Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.

  • Authors : Lamprea-Montealegre JA; Department of Medicine, University of California, San Francisco.; Kidney Health Research Collaborative, University of California, San Francisco.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/ethnology ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

  • Source: JAMA [JAMA] 2022 Sep 06; Vol. 328 (9), pp. 861-871.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

FDA Expands Empagliflozin Heart Failure Indication.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: JAMA [JAMA] 2022 Apr 05; Vol. 327 (13), pp. 1219.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/complications ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e2148030. Date of Electronic Publication: 2022 Feb 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

  • Authors : Zhou T; Yale School of Medicine, New Haven, Connecticut.; Liu P

Subjects: Atrial Fibrillation* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Heart Failure*

  • Source: JAMA internal medicine [JAMA Intern Med] 2022 Feb 01; Vol. 182 (2), pp. 185-195.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534

Record details

Read More Add to Saved list
×
Academic Journal

Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes.

  • Authors : Kaze AD; Department of Medicine, SOVAH Health, Danville, Maryland.; Santhanam P

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology; Body Weight/Body Weight/Body Weight/*physiology

  • Source: JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e220055. Date of Electronic Publication: 2022 Feb 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes.

  • Authors : Lauren BN; Department of Medicine, Columbia University Irving Medical Center, New York, New York.; Lim F

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*economics ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*therapy ; Gastric Bypass/Gastric Bypass/Gastric Bypass/*economics

  • Source: JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e2148317. Date of Electronic Publication: 2022 Feb 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015.

  • Authors : Khorrami P; Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Sinha MS

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/economics ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2140371. Date of Electronic Publication: 2022 Jan 04.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Association of Area-Level Socioeconomic Deprivation With Hypoglycemic and Hyperglycemic Crises in US Adults With Diabetes.

  • Authors : Kurani SS; Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota.

Subjects: Social Deprivation*; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*complications ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications

  • Source: JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2143597. Date of Electronic Publication: 2022 Jan 04.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types.

  • Authors : Tummalapalli SL; Division of Healthcare Delivery Science and Innovation, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.; Montealegre JL

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/economics ; Drug Costs*

  • Source: JAMA health forum [JAMA Health Forum] 2021 Dec 17; Vol. 2 (12), pp. e214205. Date of Electronic Publication: 2021 Dec 17 (Print Publication: 2021).Publisher: American Medical Association Country of Publication: United States NLM ID: 101769500

Record details

Read More Add to Saved list
×
Academic Journal

Association Between Area-Level Socioeconomic Deprivation and Diabetes Care Quality in US Primary Care Practices.

  • Authors : Kurani SS; Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.

Subjects: Health Inequities* ; Medically Underserved Area* ; Primary Health Care*

  • Source: JAMA network open [JAMA Netw Open] 2021 Dec 01; Vol. 4 (12), pp. e2138438. Date of Electronic Publication: 2021 Dec 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
  • 1-25 of  105 results for ""Humans""